Skip to main content
Zymeworks Inc. logo

Zymeworks Inc. — Investor Relations & Filings

Ticker · ZYME ISIN · US98985Y1082 LEI · 894500AHOYAGYLYZJL67 US Manufacturing
Filings indexed 306 across all filing types
Latest filing 2023-01-04 Regulatory Filings
Country US United States of America
Listing US ZYME

About Zymeworks Inc.

https://www.zymeworks.com/

Zymeworks Inc. is a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of novel, multifunctional biotherapeutics. The company focuses on creating transformational therapies for patients with difficult-to-treat cancers and other serious diseases. Its product pipeline is driven by proprietary and clinically validated technology platforms for engineering next-generation antibody-drug conjugates (ADCs) and multispecific antibody therapeutics. Zymeworks operates as a royalty-driven organization with integrated in-house research and development capabilities, managing a portfolio of licensed healthcare assets while advancing its own novel therapeutic candidates.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings
2023-01-04 English
THE SCHEDULE 13G
Major Shareholding Notification
2023-01-03 English
8-K
Regulatory Filings
2022-12-30 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-12-28 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-12-28 English
FORM 4/A SUBMISSION
Director's Dealing
2022-12-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.